0.89
Scynexis Inc stock is traded at $0.89, with a volume of 191.39K.
It is up +2.43% in the last 24 hours and up +25.53% over the past month.
SCYNEXIS Inc is a drug development company that focuses on the development and commercialization of novel anti-infectives to address unmet therapeutic needs. It is engaged in developing a product candidate, ibrexafungerp which is a novel oral and intravenous (IV) drug for the treatment of several fungal infections, including serious and life-threatening invasive fungal infections. The ibrexafungerp is a novel and structurally distinct triterpenoid glucan synthase inhibitor that is effective in vitro and in vivo against broad range of Candida and Aspergillus species, including drug-resistant strains as well as Pneumocystis, Coccidioides, Histoplasma and Blastomyces genera and some common mucorales species.
See More
Previous Close:
$0.8689
Open:
$0.8788
24h Volume:
191.39K
Relative Volume:
1.22
Market Cap:
$37.31M
Revenue:
$3.26M
Net Income/Loss:
$-19.52M
P/E Ratio:
-2.225
EPS:
-0.4
Net Cash Flow:
$-24.10M
1W Performance:
+7.05%
1M Performance:
+25.53%
6M Performance:
-10.31%
1Y Performance:
-33.58%
Scynexis Inc Stock (SCYX) Company Profile
Name
Scynexis Inc
Sector
Phone
201-884-5485
Address
1 EVERTRUST PLAZA, JERSEY CITY, NJ
Compare SCYX with other stocks
Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
---|---|---|---|---|---|---|
![]()
SCYX
Scynexis Inc
|
0.89 | 36.43M | 3.26M | -19.52M | -24.10M | -0.40 |
![]()
ZTS
Zoetis Inc
|
153.32 | 67.90B | 9.39B | 2.62B | 2.22B | 5.81 |
![]()
TAK
Takeda Pharmaceutical Co Adr
|
15.40 | 48.29B | 29.96B | 957.25M | 4.77B | 0.304 |
![]()
HLN
Haleon Plc Adr
|
9.80 | 44.04B | 14.26B | 1.98B | 2.47B | 0.4347 |
![]()
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
18.95 | 21.20B | 16.70B | -157.13M | 1.19B | -0.155 |
![]()
UTHR
United Therapeutics Corp
|
400.52 | 17.21B | 2.99B | 1.21B | 1.13B | 25.06 |
Scynexis Inc Stock (SCYX) Upgrades & Downgrades
Date | Action | Analyst | Rating Change |
---|---|---|---|
Jan-22-21 | Initiated | Guggenheim | Buy |
Jan-06-21 | Initiated | Cantor Fitzgerald | Overweight |
Jul-11-18 | Upgrade | Needham | Hold → Buy |
Jun-27-18 | Initiated | Maxim Group | Buy |
Oct-24-17 | Initiated | Guggenheim | Buy |
Jul-10-17 | Initiated | ROTH Capital | Buy |
May-09-17 | Downgrade | Needham | Buy → Hold |
Mar-03-17 | Reiterated | RBC Capital Mkts | Outperform |
Oct-20-16 | Initiated | H.C. Wainwright | Buy |
Oct-07-16 | Upgrade | WBB Securities | Buy → Strong Buy |
Oct-03-16 | Resumed | Brean Capital | Buy |
Aug-17-16 | Initiated | Guggenheim | Buy |
Aug-09-16 | Reiterated | Needham | Buy |
Aug-09-16 | Upgrade | WBB Securities | Speculative Buy → Buy |
Mar-28-16 | Initiated | Brean Capital | Buy |
Dec-29-15 | Initiated | WBB Securities | Speculative Buy |
Nov-16-15 | Reiterated | RBC Capital Mkts | Outperform |
Jun-10-15 | Initiated | Needham | Buy |
May-29-14 | Initiated | Canaccord Genuity | Buy |
May-29-14 | Initiated | RBC Capital Mkts | Outperform |
View All
Scynexis Inc Stock (SCYX) Latest News
What’s next for SCYNEXIS Inc. stock priceJobs Report & Free Technical Pattern Based Buy Signals - Newser
What are SCYNEXIS Inc.’s recent SEC filings showing2025 Price Momentum & Verified Chart Pattern Trade Signals - خودرو بانک
Is SCYNEXIS Inc. currently under institutional pressureQuarterly Performance Summary & Trade Opportunity Analysis - خودرو بانک
Can SCYNEXIS Inc. disrupt its industry2025 Technical Patterns & Verified Technical Trade Signals - خودرو بانک
Can SCYNEXIS Inc. sustain its profitability2025 Support & Resistance & Momentum Based Trading Ideas - خودرو بانک
SCYNEXIS Inc. stock chart pattern explainedWeekly Trade Summary & Low Drawdown Investment Strategies - Newser
Is SCYNEXIS Inc. stock a smart retirement pickTrade Risk Summary & Smart Allocation Stock Tips - خودرو بانک
Will SCYNEXIS Inc. be affected by tariffs2025 Bull vs Bear & Free Accurate Trade Setup Notifications - خودرو بانک
How high can SCYNEXIS Inc. stock goEarnings Recap Report & Low Drawdown Investment Ideas - Newser
Will earnings trigger a reversal in SCYNEXIS Inc.2025 EndofYear Setup & Intraday High Probability Alerts - Newser
Investors' Lawsuit Against Scynexis Dismissed, Case Closed - TradingView
Institutional scanner results for SCYNEXIS Inc.July 2025 Pullbacks & Safe Capital Growth Plans - Newser
applying wyckoff theory to scynexis inc. stockJuly 2025 Selloffs & Risk Controlled Daily Plans - Newser
Applying Wyckoff theory to SCYNEXIS Inc. stock2025 Bull vs Bear & Verified Entry Point Signals - Newser
SCYNEXIS Inc. stock trend forecastTrade Risk Report & Weekly Sector Rotation Insights - Newser
SCYNEXIS to Present Promising Data on SCY-247's Antifungal Activity at TIMM-12 Congress - Quiver Quantitative
SCYNEXIS to Present Data on SCY-247 at TIMM-12 Congress: Broad Spectrum of Antifungal Activity Against Candida and Aspergillus Species - AInvest
Breakthrough Against Deadly Superbug: SCYNEXIS's New Drug Shows Promise Against Resistant C. auris Infections - Stock Titan
Applying big data sentiment scoring on SCYNEXIS Inc.July 2025 Breakouts & Reliable Trade Execution Plans - Newser
Using economic indicators to assess SCYNEXIS Inc. potentialProduct Launch & Accurate Buy Signal Alerts - Newser
Can SCYNEXIS Inc. ride the EV waveQuarterly Trade Summary & Stepwise Entry/Exit Trade Alerts - خودرو بانک
Is SCYNEXIS Inc. building a consolidation baseVolume Spike & Weekly Watchlist for Hot Stocks - Newser
Applying sector rotation models to SCYNEXIS Inc.Entry Point & Long-Term Capital Growth Strategies - Newser
Understanding SCYNEXIS Inc.’s price movementJuly 2025 Pullbacks & Detailed Earnings Play Strategies - Newser
Can volume confirm reversal in SCYNEXIS Inc.2025 Growth vs Value & Safe Entry Momentum Stock Tips - Newser
Can swing trading help recover from SCYNEXIS Inc. losses2025 EndofYear Setup & Safe Swing Trade Setups - Newser
What are analysts’ price targets for SCYNEXIS Inc.July 2025 Gainers & Verified Chart Pattern Signals - خودرو بانک
Using portfolio simulators with SCYNEXIS Inc. includedJuly 2025 Update & Accurate Intraday Trading Signals - Newser
Scynexis Released from Investor’s Lawsuit Over Drug Recall Risk - Bloomberg Law News
Real time alert setup for SCYNEXIS Inc. performanceJuly 2025 PreEarnings & Capital Efficient Trading Techniques - Newser
Tools to monitor SCYNEXIS Inc. recovery probabilityEarnings Beat & Weekly High Conviction Trade Ideas - Newser
Does SCYNEXIS Inc. align with a passive investing strategy2025 Major Catalysts & Reliable Price Action Trade Plans - خودرو بانک
Will SCYNEXIS Inc. Reverse From Oversold Conditions getLinesFromResByArray error: size == 0 - thegnnews.com
Will SCYNEXIS Inc. Hold Gains Into Close getLinesFromResByArray error: size == 0 - 강소기업뉴스
Using RSI to spot recovery in SCYNEXIS Inc.2025 Sector Review & Growth Focused Stock Pick Reports - Newser
Published on: 2025-09-01 06:33:03 - Newser
Reversal Confirmed SCYNEXIS Inc. Stock Rallies Above MA2025 Earnings Surprises & Fast Gain Swing Alerts - beatles.ru
Volatility clustering patterns for SCYNEXIS Inc.July 2025 Technicals & Verified Momentum Stock Watchlist - Newser
Technical analysis overview for SCYNEXIS Inc. stockMarket Sentiment Report & Consistent Income Trade Recommendations - Newser
Can SCYNEXIS Inc. hit a new high this monthBuy Signal & Risk Controlled Stock Alerts - Newser
Scynexis Inc Stock (SCYX) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):